15 May 2002
The impact of very late revascularization of occluded infarct-related artery on cardiac mortality and the incidence of sudden death in survivors of acute myocardial infarction -long-term observation.
Maciej Kośmider, Ryszard Jaszewski, Paweł Ptaszyński, Halina Bolińska, Jan Ruta, Krzysztof Jerzy Wranicz, Marcin Rosiak, Janusz ZasłonkaMed Sci Monit 2002; 8(5): CR364-370 :: ID: 420835
Abstract
BACKGROUND: In survivors of acute myocardial infarction (AMI), an occludedinfarct-related artery (IRA) is an important predictor of cardiac death (CD) and sudden death (SD). Earlyreperfusion of the IRA was associated with improved survival rate. The purpose of the present study wasto assess if late IRA revascularization, performed 10-30 days after AMI, also has a beneficial effecton the incidence of CD and SD during an 18-month follow-up. MATERIAL/METHODS: The study population consistedof 93 post-MI patients with occluded IRA on coronary angiography. The patients were divided into 2 groupsaccording to IRA status at discharge -- revascularized (47 patients) or occluded (46 patients) -- andfollowed. Before revascularization, the two groups of patients did not differ in the prevalence of clinicaland angiographic variables, or in the incidence of risk factors for SD. In patients who underwent angioplastyor bypass graft surgery of closed IRA, the markers of electrical instability demonstrated no significantimprovement after revascularization. RESULTS: During the 18-month follow-up a significantly lower incidenceof CD (0% vs 15%, p<0.01) and SD (0% vs 11%, p<0.03) was observed in the group of patients with revascularized IRA than in the group of patients with occluded IRA.
Conclusions: In survivors of AMI, late reperfusion of occluded IRA is associated with reduced 18-month cardiac mortality. The beneficial effect of this procedure on the incidence of sudden death, not associated with improvement in myocardial electrical stability, suggests that ischemia can be considered an important factor modulating the arrhythmogenic substrate.
Keywords: Angioplasty, Transluminal, Percutaneous Coronary, Coronary Artery Bypass, Death, Sudden, Follow-Up Studies, Risk Factors, Time Factors
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952